Susan Hasty, Publisher
Table of Contents . . . October 6th, 2003
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Hepatitis Weekly | Other Publications
Hepatitis C Diagnosis - The MagNA pure LC reduces laborious HCV sample preparation
Viral Genomics - The INNO-LiPA assay can quickly identify hepatitis B virus variants
Antiviral Therapy - Limitin is similar to but distinct from interferon-alpha as hepatitis C therapy
Chronic Hepatitis C - Adenovirus-mediated interferon-alpha gene transfer blocks HCV replication
Liver Disease - Thioredoxin transfection protects liver cells from apoptosis and necrosis
Zoonosis - Subclinical hepatitis E virus prevails among humans and swine in Korea
Drug Resistance - Pretreatment HCV hypervariable region 1 status predicts treatment outcomes
Hemodialysis - Brazilian dialysis units are implicated in viral hepatitis transmission
Hepatitis - Hepatitis vaccine approved for sale in Argentina
Hepatitis B and C - Risk posed by discarded needles and syringes
Hepatology - Normal and tumor human and murine liver NKT cells are dissimilar
Immunology - Monoclonal antibody to activated murine lymphocyte domain blocks liver damage
Ischemic Hepatitis - Hypotension-related liver disease clears upon hemodynamic support
Personnel - Levin named to scientific advisory board at infectious disease firm
Primary Immunodeficiency Disease - Product approved to treat primary humoral immune deficiency disease
Recombinant - Hepatitis B virus X protein disturbs calcium signals to stimulate apoptosis
Substance Abuse - Hepatitis C on the increase among injecting drug users
Viral Genomics - Hepatitis C virus subgenomes replicate in nonhepatic human and murine cells
Viral Proteomics - Hepatitis B virus X protein triggers survival signals by activating enzyme
Virology - Recombinant variants protect against CTL escape and viral persistence in mice
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.